SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-001022
Filing Date
2015-02-26
Accepted
2015-02-26 16:36:39
Documents
2
Period of Report
2015-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atra-8k_20150226.htm 8-K 26496
2 EX-99.1 atra-ex991_2015022616.htm EX-99.1 259920
  Complete submission text file 0001564590-15-001022.txt   287535
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 15653094
SIC: 2836 Biological Products, (No Diagnostic Substances)